UBAP2L and endometrial cancer: Proteomic analysis revealed 105 common proteins altered in ECC-1 and RL95-2 cells upon DEAB treatment, suggesting ALDH18A1, SdhA, and UBAP2L as potential markers for endometrial cancer.